SEC Form 5 · accession 0001192482-19-000084
Recro Pharma, Inc. · REPH
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Geraldine Henwood
Officer — President and CEO · Director
Period of report
Dec 31, 2018
Accepted (ET)
Feb 14, 2019 · 5:09 pm EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001588972
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Nov 27, 2018 | G | 35,000 | $0.00 | D | 144,231 | D | |
| Common Stock | Nov 27, 2018 | G | 10,000 | $0.00 | D | 134,231 | D | |
| Common Stock | holding | — | — | — | 50,000 | I | By Spouse |
Table II — derivative securities
No Table II lines on this filing.